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           In B cells, the importance of formation of a macro-
molecular signaling complex has been suggested 
in activation of the I     B kinase (IKK)  –  NF-     B 
pathway (  1, 2  ). Upon BCR engagement, pro-
tein kinase C (PKC)       is activated, which in 
turn is important for IKK activation (  3, 4  ). In 
addition to PKC     , BCR stimulation requires 
the adaptor molecules caspase recruitment domain 
(CARD) 11, Bimp3 (CARMA1), Bcl10, and 
mucosal-associated lymphoid tissue 1 (MALT1) 
to activate the IKK complex, consisting of two 
catalytic subunits (IKK      and IKK     ) and a regula-
tory subunit (IKK     /NF-     B essential modulator) 
(  1, 5  ). Physical interactions between CARMA1  –
  Bcl10, Bcl10  –  MALT1, and CARMA1  –  MALT1 
proteins have suggested that inducible com-
plex formation is required for signal propaga-
tion (  5, 6  ). Indeed, overexpression of CARMA1 
enhances PMA- and Bcl10-dependent NF-
     B activation that is blocked by expression 
of CARMA1 lacking the Bcl10-interacting 
domain, demonstrating that CARMA1 acts 
upstream of Bcl10 (  7, 8  ). Collectively, these ob-
servations indicate that CARMA1 acts as a 
molecular scaffold to organize the complex 
formation, including Bcl10 and MALT1 for 
IKK activation. 
  Until recently, the molecular mechanism 
underlying the requirement for PKC     in IKK ac-
tivation has remained unclear, but data emerging 
from us and others demonstrate that PKC     -
dependent phosphorylation of CARMA1 favor-
ably associates with IKK activation (  6, 9  –  11  ). 
In addition, one of these studies shows that 
mouse Ser564, Ser649, and Ser657 residues in 
the central linker domain of CARMA1 are po-
tential in vitro PKC     -mediated phosphoryla-
tion sites (  9  ). However, direct evidence is still 
lacking about whether these potential sites are 
indeed phosphorylated in in vivo contexts, and 
whether these sites are critical for BCR-mediated 
IKK activation. Moreover, considering the im-
portance of phosphoinositide 3-kinase (PI3K)  –
  dependent kinase 1 (PDK1) in TCR-mediated 
NF-     B activation (  12  ), PKC     -mediated phos-
phorylation of CARMA1 may not be the sole 
mechanism to explain the action modes of 
CARMA1 in BCR signaling. 
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  Protein kinase C (PKC)      has been reported (Shinohara, H., T. Yasuda, Y. Aiba, H. Sanjo, 
M. Hamadate, H. Watarai, H. Sakurai, and T. Kurosaki. 2005.   J. Exp. Med.   202:1423–1431; 
Sommer, K., B. Guo, J.L. Pomerantz, A.D. Bandaranayake, M.E. Moreno-Garcia, Y.L. Ovechkina, 
and D.J. Rawlings. 2005.   Immunity.   23:561–574) to play a crucial role in B cell receptor 
(BCR)  –  mediated I    B kinase (IKK) activation through phosphorylation of caspase recruitment 
domain 11, Bimp3 (CARMA1). However, it remains unclear whether this PKC    -mediated 
phosphorylation accounts fully for the activation status of CARMA1, because involvement of 
other kinases, such as phosphoinositide 3-kinase  –  dependent kinase 1, has also been sug-
gested. We show that PKC     mediates phosphorylation of CARMA1 on Ser668, which in turn 
is essential for BCR-mediated CARMA1  –  Bcl10  –  mucosal-associated lymphoid tissue 1 
(MALT1) association and subsequent IKK activation. Our analyses also demonstrate that the 
downstream kinase IKK     contributes to facilitating formation of the complex CARMA1  –
  Bcl10  –  MALT1 by mediating phosphorylation of CARMA1. Hence, our data suggest that PKC     
is crucial for initial activation of IKK. The activated IKK     does not merely function as an 
effector enzyme but also modifi  es the upstream signaling complex through a feedback 
mechanism, thereby optimizing the strength and duration of the nuclear factor     B signal. 3286 A FEED-FORWARD REGULATORY LOOP THROUGH I     B KINASE       | Shinohara et al.
    Figure 1.         Multiple Ser/Thr residues of CARMA1 are important for BCR-mediated IKK activation.   (A) Schematic diagram of various CARMA1 mutants. 
Arrowheads represent the mutated amino acid indicated as T119A (left). (B) BCR-mediated IKK, ERK, and JNK activation in wild-type and CARMA1-defi  cient 
(CARMA1      /     ) DT40 B cells. IKK kinase assay was measured by phosphorylation of GST-I    B     as a substrate and detected by anti  –  phos-pho-I    B       mAb  (left). JEM VOL. 204, December 24, 2007 
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  In this paper, we show that PKC      mediates phosphoryla-
tion of CARMA1 on Ser668, which in turn is essential for 
the CARMA1  –  Bcl10  –  MALT1 association and subsequent 
IKK activation. We also provide evidence that the activated 
IKK      functions as a positive modifi  er for the upstream sig-
naling complex, at least partly by mediating phosphorylation 
of CARMA1. 
    RESULTS   
  Importance of multiple Ser/Thr residues in BCR-mediated 
IKK activation 
  Given the previous evidence that BCR-mediated CARMA1 
phsophorylation is decreased in PKC     -defi  cient chicken 
DT40 B cells (  6  ), we searched the chicken CARMA1 se-
quence with the protein database motif engine NetPhos 2.0 
(available at http://www.cbs.dtu.dk/services/NetPhos/) to 
identify its putative phosphorylation sites mediated by PKC     . 
Nine potential residues     chicken Thr119, Ser575, Ser578, 
Ser631, Ser660, Ser668, Ser715, Ser909, and Ser912     gave a 
signifi  cant score (  Fig. 1, A and E  ).   To test whether these 
potential phosphorylation modifi  cations alter CARMA1 func-
tion, each site was mutated, and the resulting mutants harbor-
ing C-terminal Flag tag were expressed in CARMA1-defi  cient 
DT40 B cells. For each mutant, multiple clones were tested 
for functional analysis. Representative clones are presented in 
  Fig. 1 C  . Expression levels of S575A and S660A mutants were 
lower than other CARMA1 mutants; clones expressing high 
amounts of these mutant CARMA1 could not be obtained, 
despite our tremendous eff  orts. Expression of BCR was com-
parable in DT40 B cell lines expressing these mutant CARMA1 
proteins (unpublished data). Then, we examined the eff  ects of 
these mutations on BCR-mediated IKK activation (  Fig. 1 C  ). 
Based on the criteria of to what extent BCR-mediated IKK 
activation is restored, we classifi  ed these mutants into three 
types: (a) similar to wild-type CARMA1, mutants of S660A, 
S715A, and S912A completely restored IKK activation; 
(b) restoration was observed, but to a lesser extent compared 
with wild-type CARMA1 (in the case of S575A and S631A 
mutants); and (c) mutants of T119A, S578A, S668A, and S909A 
failed in restoration or barely restored IKK activation after BCR 
stimulation. Before BCR stimulation, the IKK activation status 
of the T119A and S909A mutants was reproducibly increased, 
whereas that of the S578A and S668A mutants was decreased. 
  Because CARMA1 is also required for BCR-mediated 
c-Jun N-terminal kinase (JNK) activation (  Fig. 1 B  ) in the second 
and third classes of mutants, we further examined their eff  ects 
on JNK activation. Overall, these mutants gave rise to defects 
in JNK activation similar to those in IKK activation, except 
that the S631A mutant manifested the same level of JNK acti-
vation as wild-type CARMA1 (  Fig. 1 D  ). Collectively, these 
data indicate that Thr119, Ser578, Ser668, and Ser909 of 
CARMA1 play a critical role in IKK as well as JNK activation 
upon BCR engagement. Therefore, we focused our study on 
the regulation of CARMA1 function through Thr119, Ser578, 
Ser668, and Ser909. 
  Thr119, Ser578, and Ser668 on CARMA1 are 
phosphorylated upon BCR engagement 
  To examine whether Thr119, Ser578, Ser668, and Ser909 
residues on CARMA1 are indeed phosphorylated in BCR 
signaling, we generated antibodies specifi  c for the phosphory-
lated peptides centered on Thr119, Ser578, Ser668, and 
Ser909 (anti-pT119, -pS578, -pS668, and -pS909). The spec-
ifi  city of three antibodies is demonstrated in   Fig. 2 A   by the 
lack of detection of the T119A, S578A, and S668A mutants 
after BCR stimulation.   These three sites were also phosphory-
lated in endogenous CARMA1 upon BCR stimulation (see 
  Fig. 4 C  ). Thus, we conclude that Thr119, Ser578, and Ser668 
undergo phosphorylation upon BCR engagement. However, 
in the case of Ser909, although anti-pS909 antibody recog-
nized the phosphopeptide more effi   ciently than the nonphos-
phopeptide, we could not detect signifi  cant diff  erences in the 
band intensity between wild-type CARMA1 and its S909A 
mutant (unpublished data). Hence, it is more likely that Ser909 
contributes to CARMA1 function by its structural role rather 
than phosphorylation, although we cannot completely exclude 
the possibility that the level of Ser909 phosphorylation is low, 
thereby hindering our detection system. 
  Deletion of PKC      almost completely abolished phosphor-
ylation of Ser668. The phosphorylation status of Thr119 and 
Ser578 was decreased in the absence of PKC      but still oc-
curred (  Fig. 2 B  ). Because Ser668 was phosphorylated in vitro 
by the addition of active PKC      (  Fig. 2 C  ), we conclude that 
PKC      is able to phosphorylate Ser668 on CARMA1. In con-
trast to wild-type CARMA1, the S668A CARMA1 mutant 
failed to make an inducible association with Bcl10 and MALT1 
(  Fig. 2 D ). Given our previous evidence that wild-type CARMA1 
cannot make such inducible association with Bcl10  –  MALT1 
in the absence of PKC      (  6  ), these above results demonstrate 
that PKC     mediates phosphorylation of CARMA1 on Ser668, 
which in turn is essential for its association with Bcl10 –  MALT1 
and subsequent IKK activation. 
  Thus, a question arises as to what is a responsible kinase for 
phosphorylating Thr119 and Ser578, presumably in coopera-
tion with PKC     . Because the previous report showed that 
PDK1 participates in IKK activation in the context of TCR 
Phospho-ERK and -JNK were analyzed by Western blotting (middle and right). (C) For functional analysis of CARMA1 mutants, IKK kinase assay was 
performed as in B. Wild-type and mutated Flag-tagged CARMA1 cDNAs were transfected into CARMA1      /      DT40 B cells. Induced IKK activity was quantitated 
with Multi Gauge software (Fujifi  lm) and represented as fold activation compared with time zero of the wild type. (top) Protein expression of wild-type 
and mutated CARMA1, detected by Western blotting with anti-Flag mAb (1   ×   10  6   cells per lane). (D) For JNK activation, whole-cell lysates (2   ×   10  6   cells 
per lane) were analyzed by Western blotting with anti  –  phospho-JNK antibody. (E) Sequence aliments of the important Ser/Thr residues between 
chicken, mouse, and human CARMA1. wt, wild type.   
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T cell activation (  13  ). This prompted us to consider the idea 
that IKK      could participate in the phosphorylation of Thr119 
and Ser578. To address this point, we generated IKK     -defi  -
cient DT40 B cells. As expected, BCR-mediated IKK activa-
tion was abolished in the mutant cells (  Fig. 4, A and B  ).   The 
phosphorylation status of Ser578 was inhibited in IKK     -
defi  cient DT40 B cells, although its phosphorylation at 3 and 
10 min took place to some extent (  Fig. 4 C  ). To further de-
termine the requirement of its kinase activity, kinase-inactive 
IKK      (  1  ) was introduced by using a knock-in method (one 
allele containing knockout and the second allele containing 
kinase-inactive IKK     ;   Fig. 4 D  ). As shown in   Fig. 4 E  , these 
mutant cells failed to restore phosphorylation of Ser578. Because 
Ser578 was phosphorylated in vitro by the addition of re-
combinant, purifi  ed IKK      (  Fig. 4 F  ), we conclude that IKK      
is able to phosphorylate Ser578. Collectively, these data sug-
gest that IKK      contributes to mediating phosphorylation of 
CARMA1 on Ser578. In the case of Thr119 and Ser668, the 
loss of IKK      suppressed phosphorylation of these sites at early 
time points (  Fig. 4 C  ), and this decreased phosphorylation of 
Thr119 and Ser668 appeared to be, at least in part, restored 
in DT40 cells expressing the kinase-inactive IKK      (  Fig. 4 E  ). 
signaling (  12  ), one candidate could be PDK1. To address this 
possibility, we tried to establish PDK1-defi  cient DT40 B cells. 
A conventional knockout method did not allow us to obtain 
PDK1-defi  cient DT40 B cells, simply suggesting that PDK1 is 
essential for DT40 B cell survival and/or proliferation. Hence, 
we used a tamoxifen-induced Cre recombination system to 
establish PDK1-defcient DT40 B cells in a conditional way 
(  Fig. 3 A  ).   Treatment of tamoxifen for 44 h almost abolished 
expression of PDK1; however,     7% of PDK1 protein, deter-
mined by densitometric scanning, was still remaining in these 
conditions (  Fig. 3 B  , bottom). As shown in   Fig. 3 B  , despite 
almost complete inhibition of BCR-mediated Akt activation, 
NF-     B was still activated in DT40 cells conditionally defi  -
cient in PDK1 after a 44-h tamoxifen treatment. Therefore, it 
is unlikely that PDK1 plays a signifi  cant positive role in BCR-
mediated IKK activation, although we cannot completely ex-
clude the possibility that the remaining     7% of PDK1 is 
suffi   cient for NF-     B activation. 
  Phosphorylation of Ser578 is mediated by IKK     
  It has been recently reported that IKK      is required for the 
initial association of Bcl10 and MALT1 with CARMA1 after 
    Figure 2.         Thr119, Ser578, and Ser668 on CARMA1 are phosphorylated upon BCR stimulation.   (A) Cytosolic extracts (from 2   ×   10  7   cells per sample) 
were immunoprecipitated with anti-Flag mAb and analyzed by Western blotting. The phosphorylated CARMA1 was detected by each phosphospecifi  c 
antibody (anti-pT119, -pS578, and -pS668). The arrowhead indicates the position of phosphorylated S578 of CARMA1. (B) Phosphorylation status of 
CARMA1 in wild-type or PKC    -defi  cient (PKC         /     ) DT40 cells was determined by the same procedures as in A. (C) For in vitro PKC      kinase assay, purifi  ed 
Flag-tagged CARMA1 protein was used as a substrate. Phosphorylated CARMA1 was analyzed by Western blotting with anti  –  phospho-S668 antibody. 
(D) For association of Bcl10 or MALT1 with CARMA1, wild-type and mutated Flag-tagged CARMA1 cDNAs were transfected with pBIG vectors, as described in 
Materials and methods, into CARMA1      /      DT40 B cells. Cell lysates (from 3   ×   10  7   cells per sample) were immunoprecipitated by anti-Flag mAb and analyzed 
by Western blotting using anti-Bcl10 mAb or anti-MALT1 antibody. WCL, whole cell lysate; wt, wild type.     JEM VOL. 204, December 24, 2007 
ARTICLE
3289
as well as in DT40 B cells harboring kinase-inactive IKK      
(  Fig. 4 E  ), the initial CARMA1  –  Bcl10  –  MALT1 association was 
signifi  cantly suppressed. Like the S578A mutant, the T119A 
mutant also manifested the reduced association with Bcl10 
and MALT1 (  Fig. 5 B  ). 
    DISCUSSION   
  Previous studies have established the contention that IKK      func-
tions downstream of PKC    , CARMA1, Bcl10, and MALT1 
on the route of BCR-mediated IKK  –  NF-     B activation (  1, 2  ). 
In this study, we present evidence that, in response to BCR 
activation, IKK      is not only required for I     B phosphoryla-
tion but also modifi  es assembly of the upstream CARMA1  –
  Bcl10  –  MALT1 complex. Hence, we propose a model whereby 
two kinases, PKC      and IKK     , sequentially regulate the 
CARMA1  –  Bcl10  –  MALT1 complex. First, PKC     -mediated 
phosphorylation of CARMA1 at Ser668 induces the primary 
CARMA1  –  Bcl10  –  MALT1 complex formation and IKK      
activation. Subsequently, IKK      modifi  es phosphorylation 
Because phosphorylation of Thr119 and Ser668 could not 
be detected by recombinant, purifi  ed IKK      in our experi-
mental conditions, it is likely that IKK      contributes to the 
initial phosphorylation of Thr119 and Ser668 in a kinase-
independent manner. 
  Loss of IKK      inhibited phosphorylation of Ser578 1 min 
after BCR stimulation, simply suggesting that IKK      might be 
activated at 1 min after BCR stimulation, although the level 
is low. Thus, we examined the time kinetics of IKK activation in 
more detail. As shown in   Fig. 5 A   (bottom), IKK      was indeed 
activated, albeit to a small extent, 1 min after BCR engagement.   
Because IKK      activation is primarily dependent on PKC      in 
BCR signaling, these observations imply the idea that the 
primed IKK     , in turn, could promote phosphorylation of 
Ser578 on CARMA1, thereby contributing to maximal IKK 
activation by enhancing CARMA1  –  Bcl10  –  MALT1 association. 
In support of this idea, the S578A CARMA1 mutant exhib-
ited the reduced level of its association with Bcl10 and MALT1 
(  Fig. 5 B  ). Moreover, in IKK     -defi  cient DT40 B cells (  Fig. 5 C  ) 
    Figure 3.         Conditional PDK1 deletion shows normal BCR-mediated IKK activation.   (A) The PDK1 genotype was analyzed by PCR using the follow-
ing primer pairs: X (tgtggcagcagacagggatctaacatggagagtactgcagctgaatca) and Y (cttctgtgaggagcaattggcgtcgacgtgcaaata) for the fl  oxed allele, or Z (agt-
taggaagcatcatgagatgagcacatgcttacatcttctg) and W (gcacaaacagttactcgtcctatatacgcttcaatatgtactgccg) for the       allele. (left) PCR analysis of genomic DNA. 
After treatment of tamoxifen for 44 h (+), only the       allele genome product (3 kbp by using Z and W primers) was detected, and the fl  oxed allele product 
(1.5 kbp by using X and Y primers) was not amplifi  ed. (right) Scheme shows the targeting strategy. The conditional targeting vector was created with 
PDK1 cDNA from exon 3 to stop codon with polyA sequence, and the Cre recombinase enzyme with a mutated ligand-binding domain of the estrogen 
receptor (Cre-ER) under control of actin promoter, fl  anked by two loxP sites. The construct also contained a blasticidine-resistant gene (Bsr) cassette. 
(B) For analysis of PDK1  –  conditional knockout DT40 (CKO) cells, cells were treated with (+) or without (     ) 500 nM of 4OH-T for 44 h. IKK kinase assay was 
performed as in   Fig. 1  , and phospho-Akt, -ERK, and -JNK were analyzed by Western blotting.     3290 A FEED-FORWARD REGULATORY LOOP THROUGH I     B KINASE       | Shinohara et al.
  Given that the IKK complex is recruited to the CARMA1 –
  Bcl10  –  MALT1 complex after antigen receptor stimulation, 
two, although not necessarily mutually exclusive, explanations 
for the eff  ects of IKK      on CARMA1 phosphorylation are 
possible. First, upon recruitment of IKK      to the CARMA1  –
  Bcl10  –  MALT1 complex, IKK      would be activated, thereby 
directly phosphorylating CARMA1. Alternatively, because 
other kinases such as PKC      are also thought to be recruited 
to the CARMA1  –  Bcl10  –  MALT1 complex, the recruited 
IKK      to the same complex might regulate these kinases, 
of CARMA1 on key residues, including Ser578, and enhances 
the assembly of CARMA1  –  Bcl10  –  MALT1, resulting in an in-
creased ability of CARMA1 to activate IKK. Although the data 
presented here reveal the involvement of PKC      and IKK      in 
the phosphorylation of CARMA1, other kinases also appear to 
participate in. For instance, phosphorylation of Thr119 still 
occurred even in the absence of either PKC      or IKK     . 
Moreover, as our study has focused on putative PKC     -mediated 
phosphorylation sites on CARMA1, it remains possible that 
additional phosphorylation sites participate in IKK activation. 
    Figure 4.         Phosphorylation of Ser578 is mediated by IKK    .   (A) The protein expression of IKK      was analyzed by Western blotting in wild-type or 
IKK    -defi  cient (IKK         /     ) DT40 cells. (B) IKK kinase assay in wild-type or IKK         /      cells was performed as in   Fig. 1  . (C) The phosphorylation status of 
endogenous CARMA1 in wild-type or IKK    -defi  cient (IKK         /     ) DT40 cells was determined. Cytosolic extracts from 6   ×   10  7   cells per sample were immuno-
precipitated with anti-CARMA1 antibody and analyzed by the indicated phospho-specifi  c antibodies. Induced CARMA1 phosphorylation was quantitated 
as in   Fig. 1 C  . (D) IKK kinase assay in hemagglutinin-tagged wild-type IKK      or its S176/181A mutant (SSAA) was performed as in   Fig. 1  . Both wild-type 
and mutant knock-in (KI) cells were generated to transfect each KI construct into IKK     +/       DT40 cells. (E) Phosphorylation of CARMA1 and recruitment of 
Bcl10 and MALT1 were examined with Flag-tagged CARMA1 transfected into wild-type  –   or SSAA-KI cells, as described in   Fig. 2 D  . Cell lysates (from 3   ×   10  7  
cells per sample) were immunoprecipitated by anti-Flag mAb and analyzed by Western blotting using the indicated antibodies. The phosphorylated 
CARMA1 was quantitated as in   Fig.1 C  . (F) For in vitro IKK      and       kinase assay, purifi  ed Flag-tagged CARMA1 was used as a substrate. Phosphorylated 
CARMA1 was analyzed by Western blotting with anti  –  phospho-S578 antibody. WCL, whole cell lysate; wt, wild type.     JEM VOL. 204, December 24, 2007 
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the mutant DT40 B cells demonstrated normal BCR-medi-
ated NF-     B activation. This diff  erence might refl  ect a distinct 
requirement for upstream signaling events in PKC      and 
PKC      activation between B and T cells, respectively; BCR-
mediated phospholipase C       activation might be suffi   cient for 
subsequent PKC      activation, whereas PKC      activation might 
require PI3K-mediated PDK1 activity in T cells, probably in 
addition to phospholipase C       activation. Supporting this pos-
sibility, PDK1 is reported to associate with PKC      in CD3/
CD28-stimulated T cells (  12  ). Alternatively, as previously 
proposed (  12  ), recruitment of CARMA1 and PKC      into the 
plasma membrane, presumably raft fractions, requires PDK1 
activity in the case of T cell activation. Then, activated PKC      
catalyzes phosphorylation of CARMA1. In contrast, both 
functions might be exerted by PKC      in B cells. 
  Ser575, Ser578, Ser631, Ser660, and Ser668 in the 
CARMA1 linker region are predicted to be potential PKC      
phosphorylation sites. Among these sites, mutation of Ser578 
or Ser668 led to an almost complete defect in BCR-mediated 
IKK activation, whereas mutation of Ser575 or Ser631 resulted 
in its partial defect. Although not being formally proven, be-
cause of the lack of antibodies toward phospho-Ser575 and 
phospho-Ser631, the extent of phosphorylation of the S575A 
or S631A mutant was decreased, as determined by anti  –  phos-
pho-Ser/-Thr antibody (unpublished data), suggesting that 
these sites are probably phosphorylated in BCR signaling. In 
regard to the functional importance of Ser668 (corresponding 
to Ser657 in mouse and Ser645 in human), two previous pa-
pers with Jurkat T cells demonstrated that this site was partially, 
rather than completely, involved in TCR/CD28-mediated 
IKK activation (  9, 10  ). The reason why BCR-mediated IKK 
activation had a more stringent requirement for phosphorylation 
thereby promoting phosphorylation of CARMA1. In this 
mechanism, the IKK      kinase activity might not be necessar-
ily required. In the case of phosphorylation of Ser578, we 
favor the former idea because of two lines of evidence: (a) 
the inhibition of phosphorylation on Ser578 in DT40 B cells 
harboring kinase-inactive IKK      and (b) the capability of 
recombinant IKK      to phosphorylate Ser578. However, 
the contribution of IKK      to the initial phosphorylation 
of Thr119 and Ser668 in a kinase-independent manner 
suggests that the latter mechanism would also operate. 
Together, we would like to propose that IKK      utilizes both 
mechanisms to promote phosphorylation of the upstream 
adaptor, CARMA1. 
  Ser578 does not mach the classical IKK consensus motif 
(DS     XXS) found in all I    B proteins,     -catenin, and FOXO3a 
(  14  –  16  ). But, the conservation of this motif seems to refl  ect 
the constraints for recognition of SCF-     TRCP E3 ligase and 
subsequent proteosomal degradation rather than an IKK phos-
phoacceptor site. The identifi  cation of other IKK      substrates will 
allow a better understanding about the molecular parameters for 
kinase recognition and IKK      consensus sequences. Although 
IKK      is one of the kinases responsible for phosphorylation of 
Ser578, the residual phosphorylation of this site in IKK     -defi  -
cient DT40 cells was clearly observed, presumably because of 
PKC     , because reduction of phosphorylation status at Ser578 
was also reproducibly observed in PKC     -defi  cient cells. 
  PDK1-knockdown Jurkat T cells, generated with the use 
of short hairpin RNA for PDK1, manifested severe defects in 
CD3/CD28-dependent NF-     B activation, although these 
knockdown cells apparently had remaining PDK1 (  12  ). De-
spite similar levels of remaining PDK1 between knockdown 
Jurkat cells and DT40 B cells conditionally defi  cient in PDK1, 
    Figure 5.         CARMA1  –  Bcl10  –  MALT1 complex formation in the mutant DT40 cells.   (A) IKK kinase assay was performed with wild-type DT40 cells. 
(B) For association of CARMA1with Bcl10 or MALT1, DT40 cells expressing Flag-tagged CARMA1 was established as described in   Fig. 2 D  . (C) For the inter-
action of CARMA1 with Bcl10 or MALT1 in IKK    -defi  cient (IKK         /     ) cells, endogenous CARMA1 was immunoprecipitated and subjected to Western blot-
ting by the indicated antibodies. WCL, whole cell lysate; wt, wild type.     3292 A FEED-FORWARD REGULATORY LOOP THROUGH I     B KINASE       | Shinohara et al.
and Malt1 (  13, 22  ). Collectively, it is reasonable to anticipate 
that IKK      can induce both positive- and negative-feedback 
loops by phosphorylating upstream signaling molecules. 
Moreover, these feedback loops are considered to be required 
for the optimal activation of NF-     B induced by antigen re-
ceptor stimulation. Thus, further studies should be aimed at 
deciphering when and where these loops can operate, thereby 
changing the strength and duration of NF-     B signals. 
  MATERIALS AND METHODS 
  Cells, antibodies, and reagents.     Wild-type and various mutant DT40 
cells were cultured as described previously (  6  ). 4-hydroxy tamoxifen (4OH-T) 
was purchased from Sigma-Aldrich. Anti  –  phospho-CARMA1 antibodies 
were obtained by immunizing rabbits with synthetic phosphorylated pep-
tides (pT119, CTRRFST(PO  3  )IVV-COOH; pS578, IMS(PO  3  )TTPEPPC-
COOH; and pS668, CPFRPS(PO  3  )VTSV-COOH). Anti  –  chicken IgM mAb, 
M4 (  6  ), was used for stimulation of BCR. The following antibodies were 
purchased: anti  –  extracellular signal-regulated kinase (ERK), anti-JNK, anti-
Bcl10 mAb (331.3), and anti-Akt (Santa Cruz Biotechnology, Inc.); anti-
PKC     II, anti-CARMA1, anti-IKK     pAb, anti-IKK    , and anti-PDK1 (Abcam); 
anti-IKK      and anti-IKK      mAbs (BD Biosciences); anti  –  phospho-ERK, anti  –
  phospho-I     B      mAb (5A5), anti  –  phospho-JNK, anti  –  phospho  –  T308-Akt, and 
anti  –  phospho  –  S473-Akt (Cell Signaling Technology); and anti-FLAG mAb 
(M2; Sigma-Aldrich). Anti-CARMA1 antibody for immuno  precipitation was 
obtained as described previously (  6  ). 
  Expression constructs and transfection.     Flag-tagged chicken wild-type 
CARMA1 and its mutant complementary DNAs (cDNAs) were generated 
by PCR. Each cDNA was cloned into the pApuro with IRES-GFP ex-
pression vector, as previously described (  6  ), or into the knock-in vector with 
IRES-GFP and the puro-resistant gene (pBIG) for introduction into the 
endogenous      -actin locus. The knock-in construct places the transgenes un-
der the control of the endogenous      -actin promoter and enables the acquisi-
tion of clones expressing the same and proper (approximately twofold higher 
than endogenous CARMA1) protein expression levels. These constructs 
were transfected into various mutant DT40 cells by electroporation. 
  Generation of IKK    - and PDK1-defi   cient DT40 cells.     Genomic 
clones of IKK      and PDK1 were obtained by PCR using oligonucleotides 
designed by the National Center for Biotechnology Information chicken 
genome database sequences (available from GenBank/EMBL/DDBJ under 
accession nos.   LOC426792   and   LOC416588  , respectively) as a primer and 
DT40 genomic DNA as a template. The targeting constructs for IKK      were 
designed for neo and hisD cassettes to replace exons 1  –  14 of the chicken 
IKK      gene. The targeting vector, pPDK1-hisD, was constructed by replacing 
the genomic fragment containing exons 3  –  6 that correspond to the mouse 
PDK1 ATP-binding domain with hisD cassette. The fi  rst allele was disrupted 
by the pPDK1-hisD, and the second allele was replaced by the conditional 
construct, which was designed as shown in   Fig. 3 A  . Like the second allele-
targeting vector for PDK1, IKK      knock-in vectors (wild type and its S176/
181A [SSAA] mutant) were constructed to make a miniature gene in the 
endogenous IKK      locus. The fi  rst allele of IKK      was disrupted by the pIKK     -
hisD, and the second allele was replaced by the knock-in targeting constructs. 
BCR expression on DT40 B cells defi  cient in IKK      and PDK1 was essentially 
the same as wild-type cells. 
  Immunoprecipitation and Western blot analysis.     Western blot analysis 
and immunoprecipitation were performed as described previously (  6  ). 
  Kinase assay.     IKK kinase assay was performed as described previously (  6  ). 
For in vitro kinase assay of PKC     , PDK1, IKK     , and IKK     , recombinant 
active kinases were purchased from Millipore. CARMA1 as a substrate was 
purifi  ed from PKC     -defi  cient DT40 cells expressing wild-type Flag-tagged 
CARMA1 (  6  ). After being lysed by 1% NP-40 lysis buff  er without phosphatase 
of Ser668 in DT40 B cells could be explained by the following 
three possibilities. First, this diff  erence might simply refl  ect a 
species diff  erence between chicken and mouse/human. Second, 
as discussed in the requirement for PDK1 between B and 
T cells, this diff  erence might refl  ect a diff  erential requirement 
for upstream kinases (PKC      vs. PKC     ) in B and T cells, re-
spectively. Ser668 could be used more dominantly as an in vivo 
phosphorylation site by PKC      in B cells, rather than PKC      in 
T cells. Finally, because we used the antigen receptor as a stim-
ulant, in contrast to co-stimulation with antigen receptors and 
coreceptors (CD3/CD28) in the case of Jurkat T cells, phos-
phorylation of Ser668 might be used more stringently in the 
antigen receptor signaling context. As CD28 is known to en-
hance antigen receptor signaling, presumably through PI3K 
activation (  17  ), such augmented PI3K might lower the thresh-
old for the requirement of Ser668 in IKK activation. 
  The available evidence indicates that Bcl10 is recruited to 
the CARD of CARMA1 and that MALT1 is recruited to 
Bcl10 through the binding of the MALT1 immunoglobulin 
domains to the region of Bcl10 located just C-terminal of the 
CARD (for review see reference   5  ). Indeed, deletion of the 
CARD of CARMA1 blocked its association with Bcl10 
and MALT1. More importantly, deletion or mutation of the 
CARD of CARMA1 abrogated CARMA1 function to acti-
vate NF-     B after TCR stimulation (  7, 18  –  20  ). In the case of 
DT40 B cells, we also observed that the CARD deletion of 
CARMA1 almost failed to associate with Bcl10  –  MALT1 as 
well as to activate BCR-mediated IKK activation (unpub-
lished data). Thus, the decreased association of the T119A, 
S578A, or S668A CARMA1 mutant with Bcl10  –  MALT1 is 
likely to be one of the major causes for why these mutants 
could not activate IKK. It has been proposed that the linker 
domain of CARMA1 in the unstimulated stage might bind to 
its own CARD through an intramolecular interaction (  21  ). 
Once Ser668 is phosphorylated, this interaction could be dis-
rupted, thereby initiating exposure of the CARMA1 CARD 
to Bcl10. In addition, given the importance of forming 
homooligomerization of CARMA1 in NF-     B activation, 
phosphorylation of Ser668 may induce or stabilize CARMA1 
oligomerization, which in turn contributes to CARMA1  –
  Bcl10  –  MALT1 association (  6, 21  ). Phosphorylation of Ser578 
probably utilizes a similar mechanism to that of Ser668 to in-
duce a conformational change of CARMA1. The location of 
Ser119 (between the N-terminal CARD–coiled-coil domains; 
  Fig. 1 A  ) might provide an insight into the action mechanism 
of its phosphorylation. Assuming that the coiled-coil domain 
binds to the CARD in the unstimulated state, this interaction 
could be disrupted by phosphorylation of Ser119, thereby 
contributing to exposing the CARD to Bcl10 as well as to 
forming homooligomerization of CARMA1. 
  Although we have revealed an as yet unappreciated role 
of IKK      in amplifying the NF-     B signal by regulating the 
upstream complex, our study does not invalidate the role of 
IKK      in dampening the NF-     B signal, as proposed in T cells. 
Recent papers have shown that IKK      phosphorylates Bcl10, 
thereby inducing its degradation and disengagement of Bcl10 JEM VOL. 204, December 24, 2007 
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inhibitor, Flag-tagged CARMA1 was immunoprecipitated by M2-beads 
(Sigma-Aldrich) and eluted by 100      g/ml of Flag peptide (NDYKDDDD-
KDYKDDDDKDYKDDDDKN). In vitro kinase assay was performed 
according to the manufacturer  ’  s instructions (Millipore). 
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